Development and validation of a size exclusion chromatography method for aggregate analysis in Pramlintide acetate injection using analytical quality by design

Pramlintide acetate (PA), a synthetic 37-amino acid analogue of human amylin used as an adjunct to mealtime insulin therapy in diabetes mellitus, is susceptible to aggregation under physicochemical stress conditions. Rigorous quantification of aggregates is essential for ensuring patient safety and regulatory compliance. This study describes the development and validation of a size exclusion chromatography with ultraviolet detection (SEC-UV) method for aggregate determination in PA injection, implemented within an Analytical Quality by Design (AQbD) framework. An Ishikawa cause-and-effect diagram and qualitative risk assessment identified mobile phase pH, ionic strength (sodium chloride concentration), and column temperature as critical method parameters (CMPs). A three-factor, three-level Box-Behnken design (BBD) comprising 17 experimental runs was employed to optimise four critical analytical attributes (CAAs): chromatographic resolution, detector sensitivity, peak tailing factor, and theoretical plate count. The optimised method employed a BioSep™ SEC-S2000 column (300 × 7.8 mm; 5 µm; 145 Å) with a mobile phase of 0.1 mM sodium acetate buffer (pH 4.53) supplemented with 89.08 mM sodium chloride, at 0.5 mL min −1 , 50.7 °C column temperature, and UV detection at 214 nm. Validation per ICH Q2 (R1) confirmed specificity, linearity ( r 2 = 0.9972; 0.05%–1.0%), precision (%RSD ≤5%), accuracy (87%–101% recovery), limit of detection (0.05%), and limit of quantification (0.10%). Multi-detector SEC-MALS identified the principal thermally induced aggregate as a pentameric species (∼20 kDa). The validated method provides a regulatory-aligned platform for routine stability monitoring and batch release testing of PA formulations, and a transferable model for SEC aggregate method development where isolated reference standards are unavailable.

Authors

Institutions

Publication Details

Journal
Acta Chromatographica
Published
2026-11-20
DOI
https://doi.org/10.1556/1326.2026.01517
Primary Topic
Analytical Methods in Pharmaceuticals
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and validation of a size exclusion chromatography method for aggregate analysis in Pramlintide acetate injection using analytical quality by design

Asalla Yakaswamy, Marri Pradeep Kumar
1 links
Acta Chromatographica
Analytical Methods in Pharmaceuticals
article

Development and validation of a size exclusion chromatography method for aggregate analysis in Pramlintide acetate injection using analytical quality by design

Asalla Yakaswamy, Marri Pradeep Kumar
article en

Abstract

Pramlintide acetate (PA), a synthetic 37-amino acid analogue of human amylin used as an adjunct to mealtime insulin therapy in diabetes mellitus, is susceptible to aggregation under physicochemical stress conditions. Rigorous quantification of aggregates is essential for ensuring patient safety and regulatory compliance. This study describes the development and validation of a size exclusion chromatography with ultraviolet detection (SEC-UV) method for aggregate determination in PA injection, implemented within an Analytical Quality by Design (AQbD) framework. An Ishikawa cause-and-effect diagram and qualitative risk assessment identified mobile phase pH, ionic strength (sodium chloride concentration), and column temperature as critical method parameters (CMPs). A three-factor, three-level Box-Behnken design (BBD) comprising 17 experimental runs was employed to optimise four critical analytical attributes (CAAs): chromatographic resolution, detector sensitivity, peak tailing factor, and theoretical plate count. The optimised method employed a BioSep™ SEC-S2000 column (300 × 7.8 mm; 5 µm; 145 Å) with a mobile phase of 0.1 mM sodium acetate buffer (pH 4.53) supplemented with 89.08 mM sodium chloride, at 0.5 mL min −1 , 50.7 °C column temperature, and UV detection at 214 nm. Validation per ICH Q2 (R1) confirmed specificity, linearity ( r 2 = 0.9972; 0.05%–1.0%), precision (%RSD ≤5%), accuracy (87%–101% recovery), limit of detection (0.05%), and limit of quantification (0.10%). Multi-detector SEC-MALS identified the principal thermally induced aggregate as a pentameric species (∼20 kDa). The validated method provides a regulatory-aligned platform for routine stability monitoring and batch release testing of PA formulations, and a transferable model for SEC aggregate method development where isolated reference standards are unavailable.

Acta Chromatographica
Advanced Numerical Research and Analysis Group (IN)
Good health and well-being
Analytical Methods in Pharmaceuticals
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Development and validation of a size exclusion chromatography method for aggregate analysis in Pramlintide acetate injection using analytical quality by design — Asalla Yakaswamy, Marri Pradeep Kumar · Acta Chromatographica (2026) | TGRS Research Map | TGRS